Dexchloramine Syrup 2mg5mL

Land: Maleisië

Taal: Engels

Bron: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Werkstoffen:

DEXCHLORPHENIRAMINE MALEATE

Beschikbaar vanaf:

DUOPHARMA MANUFACTURING (BANGI) SDN BHD

INN (Algemene Internationale Benaming):

DEXCHLORPHENIRAMINE MALEATE

Eenheden in pakket:

90 ml

Geproduceerd door:

DUOPHARMA MANUFACTURING (BANGI) SDN BHD

Bijsluiter

_Consumer Medication Information Leaflet (RIMUP) _
1
DEXCHLORAMINE SYRUP
Dexchlorpheniramine Maleate (2mg/5ml)
WHAT IS IN THE LEAFLET?
1.
What
Dexchloramine
is
used for
2.
How Dexchloramine works
3.
Before
you
use
Dexchloramine
4.
How to use Dexchloramine
5.
While you are using it
6.
Side effects
7.
Storage
and
Disposal
of
Dexchloramine
8.
Product Description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of Revision
WHAT DEXCHLORAMINE IS USED
FOR
Dexchloramine
is
used
to
prevent
and
treat
allergies
including:
•
perennial
(occurs
year-
round)
and
seasonal
allergic
rhinitis
(allergic
inflammation of the nasal
airways)
•
vasomotor
rhinitis
(runny
nose
that
is
not
due
to
allergy)
•
allergic
conjunctivitis
(inflammation
of
the
membrane
covering
the
eye)
•
pruritus
(itching)
due
to
allergic reaction
•
urticaria
(a
raised,
itchy
rash on skin.
Ask your doctor if you have
any questions about why this
medicine has been prescribed
for you. Your doctor may have
prescribed
this
medicine
for
another reason.
HOW DEXCHLORAMINE WORKS
The name of your medicine is
Dexchloramine. It contains the
active
ingredient
dexchlorpheniramine
maleate
which
is
an
antihistamine.
Histamine
is
a
chemical
released into the body during
an allergic reaction. It causes
itching and inflammation.
Dexchloramine
works
by
blocking
the
effects
of
histamine,
calming
down
the
body's
allergic
reaction
and
starting
to
relieve
the
symptoms.
BEFORE
YOU
USE
DEXCHLORAMINE
-
_When you must not use it _
Do not take this medicine if:
•
you
are
hypersensitive
to,
or
have
had
an
allergic
reaction
to
dexchlorpheniramine
or
any of the ingredients listed
at the end of this leaflet.
•
you are taking a class of
medicine
known
as
monoamine
oxidase
inhibitors
(MAOIs)
(often
taken
for
depression),
or
you
have
taken
such
a
medicine within the last 14
days.
•
the
expiry
date
(EXP)
printed
on
the
pack
has
passed.
•
the
packaging
is
torn,
shows
signs
of
tampering
or
it
does
not
look
quite
right.
-
_Before you start to use it _
You must tell your doctor

Productkenmerken

52
BASE
52mm x 112mm
Glue
Glue
Spine
62
5 22
32
5 4
52
FRONT
52mm x 329mm
Glue
37
7
27
32
32
31
31
32
2
5
4th Fold
3rd Fold
2nd Fold
1st Fold
52
INSIDE
52mm x 329mm
Glue
37
32
32
32
31
31
32
5
2
2
KEEP CONTAINER TIGHTLY CLOSED. PROTECT FROM LIGHT.
STORE IN A DRY PLACE BELOW 30°C.
KEEP OUT OF REACH OF CHILDREN
JAUHKAN DARIPADA KANAK-KANAK.
FOR INKJET PRINTING:
LOT
MFG
EXP
25MM(W) X 15MM(H)
include hypotension, headache and
paraesthesia.
CONTRAINDICATIONS
Dexchlorpheniramine
should
not
be
given to premature infants or neonates:
this group of patients has an increased
susceptibility
to
antimuscarinic
effects.
Dexchlorpheniramine
should
not
be
given
to
patients
receiving
MAO
inhibitor
therapy
and
to
patients who have shown a previous
hypersensitivity.
PRECAUTIONS
The
anticholinergic
properties
of
dexchlorpheniramine
may
cause
drowsiness, dizziness, blurred vision
and psychomotor impairment in some
patients which may seriously affect
ability to drive or operate machinery.
Anticholinergic
effects
may
also
precipitate
or
aggravate
urinary
retention in patients with bladder neck
obstruction,
symptomatic
prostatic
hypertrophy
and
predisposition
to
urinary
retention.
Increased
intraocular
pressure
may
precipitate
an attack of angle-closure glaucoma.
Dexchlorpheniramine
should
be
used
with care in patients with pyloroduodenal
obstruction,
severe
cardiovascular
disorders
and
epilepsy.
Patients
sensitive to one antihistamine may be
sensitive
to
dexchlorpheniramine
as
well.
Antihistamines
may
inhibit
the
cutaneous
histamine
response,
thus
producing
false-negative
results;
it
is
recommended that dexchlorpheniramine
be discontinued at least 72 hours before
testing begins.
DRUG INTERACTION
Concurrent use with alcohol and CNS
depressants
such
as
barbiturates,
hypnotics,
opioid
analgesics,
monoamine oxidase (MAO) inhibitors,
anxiolytic
sedatives
and
neuroleptics
may
potentiate
the
CNS
depressant
effects.
Anticholinergic
effects
may
be
potentiated
when
these
medications such as atropine, tricyclic
antidepressants and MAO inhibitors